NCT00222482View on ClinicalTrials.gov

Depakote ER in Borderline Personality Disorder

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

September 30, 2005

Conditions
Borderline Personality Disorder
Interventions
DRUG

Depakote ER

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Schulz, S. Charles, M.D.

INDIV

lead

University of Minnesota

OTHER

NCT00222482 - Depakote ER in Borderline Personality Disorder | Biotech Hunter | Biotech Hunter